United Therapeutics M&A Summary
United Therapeutics has acquired 4 companies, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
United Therapeutics’ largest acquisition to date was in 2018, when it acquired SteadyMed for $216M. It’s largest disclosed sale occurred in 2015, when it sold Rare Pediatric Disease Priority Review Voucher to AbbVie for $350M. United Therapeutics has acquired in 4 different US states. The Company’s most targeted sectors include life science (50%) and medical products (25%).
M&A Summary
-
M&A Total Activity5
- M&A Buy Activity4
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
Unlimited Searches
